The Impact of New Technology on Patient Centricity in Life Sciences
A key change is on the horizon for the life sciences industry, bringing about a shift toward greater patient influence. Consumer habits are impacting the entire product lifecycle, and in turn demanding technology that offers a more targeted and personalized experience for patients.
To better anticipate and meet patient needs, life sciences organizations must put systems in place to best capture their data and feedback. This is a potentially challenging task when you consider the massive amount of information continuously generated around patients and product development and use.
Technology Can Help Manage Big Data
The data gathered from patients must be organized and analyzed to capture key insights that can shape the drug development process. This is essential during Research and Development and clinical trials, and equally applicable in a commercial setting. The start of the drug development process can be greatly impacted and improved by patient input.
Technology such as AI, machine learning, and cloud paas can help alleviate the pressure of big data. By containing, sorting, and interpreting this information, these technologies can present organizations with the consolidated feedback they need to streamline the early stages of drug development and clinical trials.
A recent article by PricewaterhouseCoopers dives into the benefit of technology on the clinical trial process:
New digital tools and services can help biopharmaceutical companies overcome the delays and bottlenecks endemic to drug research and development and can improve patient experiences and retention during clinical trials. Making trial participation more convenient and relevant to patients can help bring new drugs to market more rapidly and distinguish products in competitive therapeutic areas. – PwC
The impact of cloud technology in particular can greatly improve the clinical trial process. From the massive amounts of patient data being created daily, cloud technology ensures that information is continuously anonymized, shared, and combined into a growing and adapting data source that can gather and store quality data from clinical trial sites around the globe.
Building on the Cloud for Patient Value
Later this month we’ll be discussing just this at ” rel=”noopener” target=”_blank”>DIA’s global annual meeting in Boston. If you plan to attend, don’t miss our session, Appian Innovation Theater: Moving Beyond Cloud with Digital Transformation to Unify Processes, Connect Data, and Turbocharge Innovation to learn more about how cloud can help innovate in the clinical trial space.
Monday June 25, 2018 5:30pm – 6:00pm
Theater 2 Exhibit Hall Boston Convention and Exhibition Center
415 Summer Street, Boston,
And be sure to visit Appian at booth #2027 to delve further into how Appian is contributing to innovation in Life Sciences.
Want to learn more about the current state of life sciences prior to joining us at DIA?
In a recent Appian Live Expert Cut, Vice-President of Global Life Sciences Evi Cohen, and Life Sciences Industry Leader Stefan Prebil sat down to discuss the big changes going on in the industry.